Reference

·

Supporting source

Thai Medical-Textile Operator Capex Wave 2024 to 2027

USD 480-820M aggregate disclosed capex

As ofFY2024 to FY2027 cumulative·Sources6·Supporting

Aggregating disclosed 56-1 and BOI project filings: Saha Pathana Inter-Holding and Thai Wacoal commit THB 2.8 billion to anti-microbial hospital linen and surgical wrap at Saraburi and Chonburi; Indorama Ventures commits USD 180 million to medical-grade polymer fibre at Rayong; Asia Fiber commits THB 1.2 billion to silver-nanoparticle and copper-oxide hospital linen; Siam Synthetic Fiber commits USD 95 million to a medical-grade non-woven plant at the Eastern Economic Corridor; Sahapat Group Lion-Saha commits THB 1.5 billion to hospital linen and surgical wrap capacity; Singer Thailand commits THB 420 million to anti-microbial gown, mask and cap capacity at Samut Prakan. Aggregate disclosed capex lands at USD 480 to 820 million across 2024 to 2027.

Figure in context

Aggregating disclosed 56-1 and BOI project filings: Saha Pathana Inter-Holding and Thai Wacoal commit THB 2.8 billion to anti-microbial hospital linen and surgical wrap at Saraburi and Chonburi; Indorama Ventures commits USD 180 million to medical-grade polymer fibre at Rayong; Asia Fiber commits THB 1.2 billion to silver-nanoparticle and copper-oxide hospital linen; Siam Synthetic Fiber commits USD 95 million to a medical-grade non-woven plant at the Eastern Economic Corridor; Sahapat Group Lion-Saha commits THB 1.5 billion to hospital linen and surgical wrap capacity; Singer Thailand commits THB 420 million to anti-microbial gown, mask and cap capacity at Samut Prakan. Aggregate disclosed capex lands at USD 480 to 820 million across 2024 to 2027.

Aggregating disclosed 56-1 and BOI project filings: Saha Pathana Inter-Holding and Thai Wacoal commit THB 2.8 billion to anti-microbial hospital linen and surgical wrap at Saraburi and Chonburi; Indorama Ventures commits USD 180 million to medical-grade polymer fibre at Rayong; Asia Fiber commits THB 1.2 billion to silver-nanoparticle and copper-oxide hospital linen; Siam Synthetic Fiber commits USD 95 million to a medical-grade non-woven plant at the Eastern Economic Corridor; Sahapat Group Lion-Saha commits THB 1.5 billion to hospital linen and surgical wrap capacity; Singer Thailand commits THB 420 million to anti-microbial gown, mask and cap capacity at Samut Prakan. Aggregate disclosed capex lands at USD 480 to 820 million across 2024 to 2027.

Time scope

FY2024 to FY2027 cumulative

Source basis

Supporting source

Interpretation notes

What this tells you

Aggregating disclosed 56-1 and BOI project filings: Saha Pathana Inter-Holding and Thai Wacoal commit THB 2.8 billion to anti-microbial hospital linen and surgical wrap at Saraburi and Chonburi; Indorama Ventures commits USD 180 million to medical-grade polymer fibre at Rayong; Asia Fiber commits THB 1.2 billion to silver-nanoparticle and copper-oxide hospital linen; Siam Synthetic Fiber commits USD 95 million to a medical-grade non-woven plant at the Eastern Economic Corridor; Sahapat Group Lion-Saha commits THB 1.5 billion to hospital linen and surgical wrap capacity; Singer Thailand commits THB 420 million to anti-microbial gown, mask and cap capacity at Samut Prakan. Aggregate disclosed capex lands at USD 480 to 820 million across 2024 to 2027.

What not to do with it

Use the linked report for interpretation and keep basis differences explicit.

Related figures

Adjacent numbers that add context without drowning the value.

2027 forecast
THB 38-58B by 2027 (vs THB 6.4-11.2B 2024)

Thailand Anti-Microbial Hospital Textile, Medical-Grade Linen and Export Market Size

Insight derivation from Saha Pathana SET:SPI FY2024, Indorama SET:IVL FY2024, Asia Fiber SET:AFC FY2024, Singer SET:SINGER FY2024, Sahapat SET:SPC FY2024, Thai Garment Council strategy 2025, Smithers global medical textile 2024

Q4 2025 extension through FY2030
10-yr CIT holiday, 0% antimicrobial-coating duty, 50% capex credit

BOI Section 8 Medical Textile Incentive Extended Q4 2025

BOI A4 Guide 2024, BOI Section 8 medical-textile extension press release December 2025, operator 56-1 disclosures

FY2025-FY2027 certification window
8-22% pricing advantage vs Chinese commodity supply

Thai Operator EU MDR 2017/745 Class IIa and US FDA 510(k) Certification Stack

EU MDR 2017/745 Class IIa rules, US FDA 510, ISO 13485, EN 13795, operator disclosures

FY2024 to FY2027 supplier diversification
6 major OEMs adding Thai supplier capacity by 2027

Foreign OEM Thai Medical-Textile Supplier Partnerships

Molnlycke press release September 2025, Cardinal Health press release August 2025, operator supplier diversification disclosures

FY2025-FY2027 licensing window
5 chemistries licensed from Korean, Japanese, Western IP partners

Thai Anti-Microbial Coating Technology Stack

Thai Textile Institute anti-microbial coating R&D programme 2025, operator IP licensing disclosures, EU MDR nanomaterial disclosure framework

FY2025 to FY2027 BCG premium window
+35-65% ASP premium versus commodity polyester

BCG Bio-Circular Green Economy Thai-Fibre Premium

MoI BCG Bio-Circular Green Economy framework February 2025, operator product-mix disclosures, Smithers global medical-textile benchmark 2024

Report context

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

Thai Medical-Textile Operator Capex Wave 2024 to 2027 · Insight